We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.05B
AUM Growth
+$688M
(+11%)
Cap. Flow
+$306M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
15.99%
Holding
1,149
New
136
Increased
453
Reduced
359
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
| 2 |
Amazon
AMZN
|
+$35M |
| 3 |
TJX Companies
TJX
|
+$34.6M |
| 4 |
Phillips 66
PSX
|
+$33.1M |
| 5 |
Mastercard
MA
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.7M |
| 2 |
Cigna
CI
|
+$27.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$21.6M |
| 4 |
JPMorgan Chase
JPM
|
+$21M |
| 5 |
Marvell Technology
MRVL
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.29% |
| 2 | Financials | 17.18% |
| 3 | Consumer Discretionary | 12.24% |
| 4 | Industrials | 11.66% |
| 5 | Healthcare | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRAY
426
DELISTED
Cray, Inc.
CRAY
| $2.98M | 0.04% |
138,741
+78,903
| +132% | +$1.82M |
|
|
GAP
427
The Gap Inc
GAP
$6.84B
| $2.98M | 0.04% |
+103,350
| New | +$3.1M |
|
|
WBC
428
DELISTED
WABCO HOLDINGS INC.
WBC
| $2.98M | 0.04% |
25,238
-130,400
| -84% | -$15.7M |
|
429
Progress Software
PRGS
$1.55B
| $2.97M | 0.04% |
84,192
-40,900
| -33% | -$1.62M |
|
430
MacroGenics
MGNX
$235M
| $2.96M | 0.04% |
137,866
-11,304
| -8% | -$241K |
|
|
LION
431
DELISTED
Fidelity Southern Corporation
LION
| $2.94M | 0.04% |
118,758
+91,948
| +343% | +$2.28M |
|
432
Akebia Therapeutics
AKBA
$327M
| $2.92M | 0.04% |
330,452
+54,299
| +20% | +$486K |
|
|
CRCM
433
DELISTED
CARE.COM, INC.
CRCM
| $2.92M | 0.04% |
131,874
-12,724
| -9% | -$255K |
|
434
Telephone and Data Systems
TDS
$3.91B
| $2.91M | 0.04% |
95,726
-143,757
| -60% | -$4.1M |
|
435
Valmont Industries
VMI
$9.44B
| $2.91M | 0.04% |
20,995
-90
| -0.4% | -$12.7K |
|
|
GCI
436
DELISTED
Gannett Co., Inc
GCI
| $2.91M | 0.04% |
290,488
+58,948
| +25% | +$604K |
|
|
BRSL
437
Brightstar Lottery PLC
BRSL
$1.91B
| $2.91M | 0.04% |
147,114
-116,256
| -44% | -$2.53M |
|
|
PBPB
438
DELISTED
Potbelly
PBPB
| $2.9M | 0.04% |
236,175
-29,675
| -11% | -$384K |
|
439
The Bancorp
TBBK
$2.79B
| $2.9M | 0.04% |
302,745
+57,558
| +23% | +$582K |
|
|
CERN
440
DELISTED
Cerner Corp
CERN
| $2.9M | 0.04% |
45,040
-23,610
| -34% | -$1.5M |
|
|
TGI
441
DELISTED
Triumph Group
TGI
| $2.88M | 0.04% |
123,756
-6,640
| -5% | -$139K |
|
442
Medtronic
MDT
$107B
| $2.88M | 0.04% |
+29,270
| New | +$2.71M |
|
|
HEES
443
DELISTED
H&E Equipment Services
HEES
| $2.87M | 0.04% |
76,017
+52,857
| +228% | +$1.91M |
|
444
Howard Hughes
HHH
$3.93B
| $2.87M | 0.04% |
24,232
+17,518
| +261% | +$2.2M |
|
445
Axalta
AXTA
$7.01B
| $2.87M | 0.04% |
+98,340
| New | +$2.95M |
|
446
HealthStream
HSTM
$793M
| $2.85M | 0.04% |
91,860
-13,309
| -13% | -$398K |
|
447
CNX Resources
CNX
$4.85B
| $2.8M | 0.04% |
195,673
+38,673
| +25% | +$614K |
|
|
MRC
448
DELISTED
MRC Global
MRC
| $2.8M | 0.04% |
148,995
+65,459
| +78% | +$1.35M |
|
449
Calix
CALX
$2.27B
| $2.76M | 0.04% |
340,361
+9,913
| +3% | +$75.7K |
|
450
Kulicke & Soffa
KLIC
$5.3B
| $2.74M | 0.04% |
114,824
-56,302
| -33% | -$1.46M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2018 Portfolio in Review
As of Q3 2018, Jacobs Levy Equity Management held 1,149 positions worth $7.05B, up 11% from $6.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $306M of net new capital in Q3 2018, opening 136 new positions and adding to 453 existing holdings. Its largest new stake was TJX Companies: 673,440 shares worth $37.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Eli Lilly, an estimated $31.7M trimmed.
- Jacobs Levy Equity Management's largest Q3 2018 buy was TJX Companies: 673,440 shares worth $37.7M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q3 2018, an estimated $40.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $31.7M.
- Jacobs Levy Equity Management fully exited Dun & Bradstreet in Q3 2018, selling an estimated $17.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $7.05B portfolio in Q3 2018.
- Jacobs Levy Equity Management opened 136 new positions and closed 174 in Q3 2018.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $7.05B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.